The Board of Directors of Santen Pharmaceutical Co., Ltd. has authorized a buyback plan on May 9, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,794 JPY | +1.10% |
|
+3.37% | +27.65% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.65% | 4.04B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Santen Pharmaceutical Co., Ltd. authorizes a Buyback Plan.